GBSI Is Taking Action to Reduce...
These Biotech Giants and Big Pharmas...
Be Aware of the Pitfalls of...
Microfluidics Is On a Roll and...
In our February 1 Point of View article, David Sokal, M.D., says that some innovative nonhormonal approaches that would be highly effective with minimal side effects and, ideally, a more rapid onset of action than hormonal methods may be on the way. S. Kean recently reported in Science on researchers working to halt sperm production; M. O’Rand et al., are working to immobilize sperm; Amobi N et al., are modifying muscle contractility of the vas to prevent passage of sperm; and an Indonesian team may have found a naturally occurring compound that prevents a man’s sperm from penetrating the woman’s egg. Would you or your partner take any of these drugs?
Do you agree that pet dogs with cancer should be used in early cancer drug trials?
Be sure to add firstname.lastname@example.org
to your Address Book or Safe Senders List.
here for instructions.
If you have any questions about your subscription, click
here to email us or call at (914) 740-2189.
You may also be interested in subscribing to the GEN magazine, an indispensable
resource for everyone involved in the business of translating discoveries at the
bench into solutions that fight disease and improve health, agriculture, and the
today to see why over 60,000 biotech professionals read GEN to
keep current in the areas of genomics, proteomics, drug discovery, biomarker discovery,
bioprocessing, molecular diagnostics, collaborations, biotech business trends, and
© 2015 Genetic Engineering & Biotechnology News All Rights Reserved